INNA RAYKHELGAUZ: Open Payments
NPI 1306103122 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $179 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $214 |
| ABBVIE INC. | 3 | $89 |
| Janssen Biotech, Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Incyte Corporation | 3 | $73 |
| Organon LLC | 3 | $67 |
| Lilly USA, LLC | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: ANZUPGO, SKYRIZI, TREMFYA, Sotyktu, OPZELURA, ADBRY, EBGLYSS, VTAMA.
Industry payments across NY — which companies pay providers there.
